These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6774438)

  • 1. Effects of alpha 1-acid glycoprotein on ristocetin, thrombin and Polybrene induced platelet aggregation.
    Coller BS
    Thromb Res; 1980 May 1-15; 18(3-4):579-84. PubMed ID: 6774438
    [No Abstract]   [Full Text] [Related]  

  • 2. Botrocetin- and polybrene-induced platelet aggregation in platelet-type von Willebrand disease.
    Takahashi H; Nagayama R; Hattori A; Shibata A
    Am J Hematol; 1985 Feb; 18(2):179-89. PubMed ID: 3871585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of trifluoperazine on aggregation of human platelets.
    Kindness G; Williamson FB; Long WF
    Thromb Res; 1980 Feb 1-15; 17(3-4):549-54. PubMed ID: 6768164
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal polybrene-induced platelet agglutination in von Willebrand's disease.
    Rosborough TK; Swaim WR
    Thromb Res; 1978 May; 12(5):937-42. PubMed ID: 307834
    [No Abstract]   [Full Text] [Related]  

  • 5. Polybrene-induced platelet agglutination and reduction in electrophoretic mobility: enhancement by von Willebrand factor and inhibition by vancomycin.
    Coller BS
    Blood; 1980 Feb; 55(2):276-81. PubMed ID: 6766335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new principle in heparin assaying based on partial neutralization of heparin with polybrene.
    Talstad I
    Thromb Res; 1980 May 1-15; 18(3-4):485-91. PubMed ID: 7414543
    [No Abstract]   [Full Text] [Related]  

  • 7. Parallel inhibition of ristocetin and polycation-induced platelet agglutination.
    Rosborough TK
    Thromb Res; 1980 Aug; 19(3):417-22. PubMed ID: 6254206
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of thrombin/antithrombin III reaction in the presence of protamine or polybrene.
    Oshima G
    Thromb Res; 1988 Sep; 51(6):565-74. PubMed ID: 3187966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody to glycoprotein Ib inhibits both thrombin- and ristocetin-induced platelet aggregations.
    Yamamoto N; Kitagawa H; Tanoue K; Yamazaki H
    Thromb Res; 1985 Sep; 39(6):751-9. PubMed ID: 2417361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species specificity in von Willebrand factor-supported platelet agglutination.
    Johnson GS; Dodds WJ; Rosborough TK
    Ann N Y Acad Sci; 1981; 370():227-35. PubMed ID: 6973945
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutralization of the local negative charge carried by glycoprotein (GP)-Ib in ristocetin-induced platelet agglutination.
    Tanoue K; Jung SM; Yamamoto N; Yamazaki H
    Thromb Haemost; 1984 Feb; 51(1):79-83. PubMed ID: 6232731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin effect on thrombin-induced platelet aggregation: evidence against a common platelet membrane receptor for thrombin and ristocetin.
    Weinger RS; Moake JL
    Thromb Res; 1978 May; 12(5):911-15. PubMed ID: 307833
    [No Abstract]   [Full Text] [Related]  

  • 13. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor.
    Kasirer-Friede A; Frojmovic MM
    Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody directed against a granule membrane glycoprotein (GMP-140/PADGEM, P-selectin, CD62P) inhibits ristocetin-induced platelet aggregation.
    Boukerche H; Ruchaud-Sparagano MH; Rouen C; Brochier J; Kaplan C; McGregor JL
    Br J Haematol; 1996 Feb; 92(2):442-51. PubMed ID: 8603015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hexadimethrine bromide (polybrene) on the infection of the primate retroviruses SSV 1/SSAV 1 and BaEV.
    Coelen RJ; Jose DG; May JT
    Arch Virol; 1983; 75(4):307-11. PubMed ID: 6301409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antimicrobial activity of protamine and polybrene.
    Mulholland B; Mellersh AR
    J Hosp Infect; 1987 Nov; 10(3):305-7. PubMed ID: 2891761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib.
    Katagiri Y; Hayashi Y; Yamamoto K; Tanoue K; Kosaki G; Yamazaki H
    Thromb Haemost; 1990 Feb; 63(1):122-6. PubMed ID: 2339348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the erythrocyte aggregating properties of polybrene and protamine sulphate.
    Inglis G; Sheridan R
    Transfusion; 1978; 18(1):84-8. PubMed ID: 625786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEAE-dextran and polybrene cation inhibition of antibody/complement mediated in vitro immune haemolysis.
    Arnung KM; Ebbesen P; Baark J; Bjerrum OJ
    Scand J Haematol; 1976 Apr; 16(4):271-8. PubMed ID: 819989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against platelet membrane glycoproteins. III. Effect on thrombin-and bovine Von Willebrand factor-induced aggregation.
    Jenkins CS; Clemetson KJ; Ali-Briggs EF
    Br J Haematol; 1983 Mar; 53(3):491-501. PubMed ID: 6600621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.